Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?
Publication
, Journal Article
Piccini, JP; Arps, K
Published in: JACC Heart Fail
May 2022
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
May 2022
Volume
10
Issue
5
Start / End Page
347 / 349
Location
United States
Related Subject Headings
- Valsartan
- Stroke Volume
- Humans
- Heart Failure
- Biphenyl Compounds
- Aminobutyrates
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., & Arps, K. (2022). Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail, 10(5), 347–349. https://doi.org/10.1016/j.jchf.2022.02.010
Piccini, Jonathan P., and Kelly Arps. “Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?” JACC Heart Fail 10, no. 5 (May 2022): 347–49. https://doi.org/10.1016/j.jchf.2022.02.010.
Piccini JP, Arps K. Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail. 2022 May;10(5):347–9.
Piccini, Jonathan P., and Kelly Arps. “Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?” JACC Heart Fail, vol. 10, no. 5, May 2022, pp. 347–49. Pubmed, doi:10.1016/j.jchf.2022.02.010.
Piccini JP, Arps K. Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail. 2022 May;10(5):347–349.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
May 2022
Volume
10
Issue
5
Start / End Page
347 / 349
Location
United States
Related Subject Headings
- Valsartan
- Stroke Volume
- Humans
- Heart Failure
- Biphenyl Compounds
- Aminobutyrates
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology